Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Jun;79(6):1879–1882. doi: 10.1172/JCI113031

Gangliosides shed by tumor cells enhance tumor formation in mice.

S Ladisch, S Kitada, E F Hays
PMCID: PMC424533  PMID: 3584474

Abstract

The role of tumor cell membrane gangliosides in tumor formation was probed using a series of cloned murine AKR lymphoma cell lines. Tumor formation was directly related to high expression and shedding of membrane gangliosides. In vivo, as little as 1 pmol of purified total gangliosides of highly tumorigenic cells, injected intradermally with poorly tumorigenic cells (which lacked and did not shed gangliosides), markedly increased the tumorigenicity of these cells in syngeneic normal mice. Thus, gangliosides shed by tumor cells are a previously unrecognized, extremely potent enhancer of tumor formation in vivo.

Full text

PDF
1879

Images in this article

1880Image
on p.1880
1880Image
on p.1880
1880Image
on p.1880

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Black P. H. Shedding from the cell surface of normal and cancer cells. Adv Cancer Res. 1980;32:75–199. doi: 10.1016/s0065-230x(08)60361-9. [DOI] [PubMed] [Google Scholar]
  2. Burnet F. M. The concept of immunological surveillance. Prog Exp Tumor Res. 1970;13:1–27. doi: 10.1159/000386035. [DOI] [PubMed] [Google Scholar]
  3. Diatlovitskaia E. V., Kliuchareva E. V., Matveeva V. A., Sinitsyna E. V., Akhmed-Zade A. Sh. Vliianie gangliozidov na tsitotoksicheskuiu aktivnost' estestvennykh killerov siriiskikh khomiakov. Biokhimiia. 1985 Sep;50(9):1514–1516. [PubMed] [Google Scholar]
  4. Feizi T. Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature. 1985 Mar 7;314(6006):53–57. doi: 10.1038/314053a0. [DOI] [PubMed] [Google Scholar]
  5. Fishman P. H., Brady R. O. Biosynthesis and function of gangliosides. Science. 1976 Nov 26;194(4268):906–915. doi: 10.1126/science.185697. [DOI] [PubMed] [Google Scholar]
  6. Gonwa T. A., Westrick M. A., Macher B. A. Inhibition of mitogen- and antigen-induced lymphocyte activation by human leukemia cell gangliosides. Cancer Res. 1984 Aug;44(8):3467–3470. [PubMed] [Google Scholar]
  7. Hakomori S., Kannagi R. Glycosphingolipids as tumor-associated and differentiation markers. J Natl Cancer Inst. 1983 Aug;71(2):231–251. [PubMed] [Google Scholar]
  8. Itaya K., Hakomori S. I., Klein G. Long-chain neutral glycolipids and gangliosides of murine fibroblast lines and their low- and high-tumourigenic hybrids. Proc Natl Acad Sci U S A. 1976 May;73(5):1568–1571. doi: 10.1073/pnas.73.5.1568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ladisch S., Gillard B. A solvent partition method for microscale ganglioside purification. Anal Biochem. 1985 Apr;146(1):220–231. doi: 10.1016/0003-2697(85)90419-1. [DOI] [PubMed] [Google Scholar]
  10. Ladisch S., Gillard B., Wong C., Ulsh L. Shedding and immunoregulatory activity of YAC-1 lymphoma cell gangliosides. Cancer Res. 1983 Aug;43(8):3808–3813. [PubMed] [Google Scholar]
  11. Ladisch S., Ulsh L., Gillard B., Wong C. Modulation of the immune response by gangliosides. Inhibition of adherent monocyte accessory function in vitro. J Clin Invest. 1984 Dec;74(6):2074–2081. doi: 10.1172/JCI111631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ladisch S., Wu Z. L. Detection of a tumour-associated ganglioside in plasma of patients with neuroblastoma. Lancet. 1985 Jan 19;1(8421):136–138. doi: 10.1016/s0140-6736(85)91906-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ledeen R. W., Yu R. K. Gangliosides: structure, isolation, and analysis. Methods Enzymol. 1982;83:139–191. doi: 10.1016/0076-6879(82)83012-7. [DOI] [PubMed] [Google Scholar]
  14. Lengle E. E., Krishnaraj R., Kemp R. G. Inhibition of the lectin-induced mitogenic response of thymocytes by glycolipids. Cancer Res. 1979 Mar;39(3):817–822. [PubMed] [Google Scholar]
  15. MacLeod C. L., Weinroth S. E., Streifinger C., Glaser S. M., Hays E. F. SL12 murine T-lymphoma: a new model for tumor cell heterogeneity. J Natl Cancer Inst. 1985 Apr;74(4):875–882. [PubMed] [Google Scholar]
  16. Merritt W. D., Bailey J. M., Pluznik D. H. Inhibition of interleukin-2-dependent cytotoxic T-lymphocyte growth by gangliosides. Cell Immunol. 1984 Nov;89(1):1–10. doi: 10.1016/0008-8749(84)90191-6. [DOI] [PubMed] [Google Scholar]
  17. Miller H. C., Esselman W. J. Modulation of the immune response by antigen-reactive lymphocytes after cultivation with gangliosides. J Immunol. 1975 Sep;115(3):839–843. [PubMed] [Google Scholar]
  18. Mora P. T., Brady R. O., Bradley R. M., McFarland V. W. Gangliosides in DNA virus-transformed and spontaneously transformed tumorigenic mouse cell lines. Proc Natl Acad Sci U S A. 1969 Aug;63(4):1290–1296. doi: 10.1073/pnas.63.4.1290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rios A., Simmons R. L. Poly-2-vinylpyridine N-oxide reverses the immunosuppressive effects of silica and carrageenan. Transplantation. 1972 Mar;13(3):343–345. doi: 10.1097/00007890-197203000-00026. [DOI] [PubMed] [Google Scholar]
  20. Rosenfelder G., Ziegler A., Wernet P., Braun D. G. Ganglioside patterns: new biochemical markers for human hematopoietic cell lines. J Natl Cancer Inst. 1982 Feb;68(2):203–209. [PubMed] [Google Scholar]
  21. Schulz G., Cheresh D. A., Varki N. M., Yu A., Staffileno L. K., Reisfeld R. A. Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients. Cancer Res. 1984 Dec;44(12 Pt 1):5914–5920. [PubMed] [Google Scholar]
  22. Schwartz R., Kniep B., Müthing J., Mühlradt P. F. Glycoconjugates of murine tumor lines with different metastatic capacities. II. Diversity of glycolipid composition. Int J Cancer. 1985 Nov 15;36(5):601–607. doi: 10.1002/ijc.2910360514. [DOI] [PubMed] [Google Scholar]
  23. Shaposhnikova G. I., Prokazova N. V., Buznikov G. A., Zvezdina N. D., Teplitz N. A., Bergelson L. D. Shedding of gangliosides from tumor cells depends on cell density. Eur J Biochem. 1984 May 2;140(3):567–570. doi: 10.1111/j.1432-1033.1984.tb08139.x. [DOI] [PubMed] [Google Scholar]
  24. Skipski V. P., Carter S. P., Terebus-Kekish O. I., Podlaski F. J., Jr, Peterson R. H., Stock C. C. Ganglioside profiles of metastases and of metastasizing and nonmetastasizing rat primary mammary carcinomas. J Natl Cancer Inst. 1981 Dec;67(6):1251–1258. [PubMed] [Google Scholar]
  25. Stanbridge E. J., Der C. J., Doersen C. J., Nishimi R. Y., Peehl D. M., Weissman B. E., Wilkinson J. E. Human cell hybrids: analysis of transformation and tumorigenicity. Science. 1982 Jan 15;215(4530):252–259. doi: 10.1126/science.7053574. [DOI] [PubMed] [Google Scholar]
  26. Whisler R. L., Yates A. J. Regulation of lymphocyte responses by human gangliosides. I. Characteristics of inhibitory effects and the induction of impaired activation. J Immunol. 1980 Nov;125(5):2106–2111. [PubMed] [Google Scholar]
  27. Wong C. G., Ladisch S. Retention of gangliosides in serum delipidated by diisopropyl ether-1-butanol extraction. J Lipid Res. 1983 May;24(5):666–669. [PubMed] [Google Scholar]
  28. Yogeeswaran G. Incorporation of asialo GM2 and gangliosides in cell surface of cultured metastatic and nonmetastatic BALB/3T3 cell lines: subcutaneous tumor cell take. J Natl Cancer Inst. 1981 Feb;66(2):303–310. [PubMed] [Google Scholar]
  29. Yogeeswaran G., Salk P. L. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science. 1981 Jun 26;212(4502):1514–1516. doi: 10.1126/science.7233237. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES